Dermatology
Cutaneous Ulcer
0
Pipeline Programs↗
0
Active Trials↗
1
Companies Involved↗
Cutaneous Ulcer is an early-stage landscape with 0 programs across 1 company. The most active players are Merakris Therapeutics.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
3
clinical trials
Available1 · 33%
Suspended1 · 33%
Completed1 · 33%
Clinical Trials
Trial Activity
Non-inferiority Clinic of Kollagenase® Compared Iruxol® in Treatment of Cutaneous Ulcers
Suspended·—·Phase 2/3·NCT00701974·66 enrolled
An Accessible Low-cost Plant Treatment for Cutaneous Ulcers
Completed·—·Phase 2·NCT04453124·150 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)